| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $166.4M | +15.4% |
| Cost of Revenue | $136.5M | +25.0% |
| R&D Expense | $19.0M | +46.2% |
| SG&A Expense | $117.1M | +87.1% |
| Operating Income | -$108.5M | -124.0% |
| Pre-tax Income | -$112.8M | -67.5% |
| Income Tax | -$440K | +74.2% |
| Net Income | -$104.8M | -68.9% |
| EPS (Basic) | -$2.89 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $491.3M | +778.5% |
| Accounts Receivable | $29.8M | +94.1% |
| Inventory | $3.8M | +150.7% |
| Current Assets | $581.3M | +472.3% |
| Total Assets | $1.05B | +324.3% |
| Current Liabilities | $133.0M | +52.2% |
| Total Liabilities | $620.9M | +230.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.9M | -139.0% |
| Capital Expenditures | $144.7M | +74.9% |
| Investing Cash Flow | -$261.6M | -841.9% |
| Financing Cash Flow | $757.8M | +859.8% |
| Free Cash Flow | -$205.6M | -90.0% |
| +56.1% |
| EPS (Diluted) | -$2.89 | +58.8% |
| Stockholders' Equity |
| $383.7M |
| +650.5% |